Grants and Contributions:
Title:
2425-HQ-000018
Agreement Number:
2425-HQ-000018
Agreement Value:
$193,804,342.00
Agreement Date:
Jul 23, 2024 - Mar 31, 2027
Description:
To provide funding to willing jurisdictions to support improving access for patients with rare diseases to drugs for rare diseases, as well as improving and broadening rare disease treatments and services, to achieve better health outcomes.
Organization:
Health Canada
Expected Results:
Improved collaboration across provincial/territorial drug plans related to drugs for rare decisions decision-making.
Canadians with rare diseases have better access to screening and diagnostic services they need.
Location:
Victoria, British Columbia, CA V8W 3C8
Reference Number:
271-2025-2026-Q1-00023
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
107864738
Recipient Type:
Government
Additional Information:
The total agreement value previously disclosed has been updated to reflect an increase resulting from this amendment.
Amendment Date
May 8, 2025
Recipient's Legal Name:
Government of British Columbia - Ministry of Health
Program:
National Strategy for Drugs for Rare Diseases Program
Program Purpose:
Canadian Health Systems and Programs
Amendments: